Skip Nav Destination
Issues
May 2006
ISSN 0003-9985
eISSN 1543-2165
In this Issue
RESIDENTS’ PAGES
CAP LABORATORY IMPROVEMENT PROGRAMS
SPECIAL SECTION—ASSOCIATION OF DIRECTORS OF ANATOMIC AND SURGICAL PATHOLOGY SYMPOSIUM
SPECIAL SECTION—WILLIAM BEAUMONT HOSPITAL DNA TECHNOLOGY IN THE CLINICAL LABORATORY SYMPOSIUM
Original Articles
Evaluation of HER-2/neu Gene Status in Osteosarcoma by Fluorescence In Situ Hybridization and Multiplex and Monoplex Polymerase Chain Reactions
Carlynn Willmore-Payne, BS, MT(ASCP); Joseph A. Holden, MD, PhD; Holly Zhou, MD; Dilip Gupta, MD; Sharon Hirschowitz, MD; Carl T. Wittwer, MD; Lester J. Layfield, MD
REVIEW ARTICLE
Case Reports
RESIDENT SHORT REVIEW
TEST YOUR MEMORY
Sponsored Video
Neoadjuvant Therapy and Lung Cancer: Role of Pathologists
Sanja Dacic, MD, PhD
Endocrine and Neuroendocrine Tumors: Updates From the 5th Edition of the World Health Organization “Blue Book”
Juan C. Hernandez-Prera, MD, Nicole Riddle, MD, MSHI, Raul S. Gonzalez, MD, Sylvia L. Asa, MD, PhD
Metastatic Malignancies to the Ovaries: Often Hiding in Plain Sight
Olivia J. Leung, MD, Keshia E. Mora, MD, PhD, Alessandro Brunetti, MD, Lauren E. Schwartz, MD
Breast Biomarker Cytology Practice in 2023: Results of a College of American Pathologists Survey
Zaibo Li, MD, PhD, Ann King, MS, Rhona J. Souers, MS, Janie J. Roberson, CT, SCT, Shahla Masood, MD, Deepu Alex, MD, PhD, Martin J. Magers, MD, Poornima Hegde, MD, Sana O. Tabbara, MD
Precision Detection of FGFR2b Protein Expression in Solid Tumors: A Comprehensive Assessment of Staining Parameters via Automated Immunohistochemistry
Autumn Sky Watson, MS, Catherine Le, PhD, Anne Wertheimer, PhD, Spencer Escobedo, PhD, Lisa So, PhD, Bhavani Bagevalu Siddegowda, PhD, John Palting, PhD, Susan Marion, MD, Steven P. Stratton, PhD, Birte Aggeler, PhD
Machine Learning Classifier Using Blood Count Parameters and Erythropoietin to Predict JAK2 Mutations in Patients With Erythrocytosis
Ron B. Schifman, MD, Keri Donaldson, MD, Daniel Luevano, MSDA, Raul Benavides, Jr, MD, Jeffery A. Hunt, BA
Reproducibility of Equivocal HER2 In Situ Hybridization Groups 3 and 4, and Comparison With HER2 mRNA Expression: The Thin Line Between Amplified and Nonamplified Breast Cancers
Ximena Baez-Navarro, MD, MSc, Julia Riggi, MD, David Zylberberg, MD, Angelique van der Made, MSc, Dominique Dubois, MSc, Jonathan Vanderveken, BSc, Naima Benhaddi, BSc, Francois P. Duhoux, MD, PhD, Hilde Vernaeve, MD, Maud Vassilieff, MD, Martine Berlière, MD, PhD, Christine Galant, MD, PhD, Carolien H. M. van Deurzen, MD, PhD, Mieke R. van Bockstal, MD, PhD
In Reply
Xiao Li, PhD, Hongyu Xie, PhD, Xinyu Wang, PhD